• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALCON RESEARCH, LLC - HUNTINGTON MONARCH III IOL DELIVERY SYSTEM, CARTRIDGE D; FOLDERS AND INJECTORS, INTRAOCULAR LENS (IOL)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALCON RESEARCH, LLC - HUNTINGTON MONARCH III IOL DELIVERY SYSTEM, CARTRIDGE D; FOLDERS AND INJECTORS, INTRAOCULAR LENS (IOL) Back to Search Results
Catalog Number 8065977763
Device Problem Device Contamination with Chemical or Other Material (2944)
Patient Problems Insufficient Information (4580); Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
Event Date 09/13/2022
Event Type  malfunction  
Event Description
A physician reported that during intraocular lens (iol) implant procedure, more or less sticky deposit on the posterior surface of the implant after injection and difficulty of removing the deposit.Additional information has been requested.There are five medical device reports associated with this event.This report is two of five.
 
Manufacturer Narrative
One used company cartridge was returned.The used company cartridge was microscopically examined.Inadequate viscoelastic was observed in the cartridge.The used company cartridge had evidence of placement into a handpiece.Top coat dye stain testing was conducted with acceptable results for the presence of top coat.Internal damage was observed with disruption in the coating on left side of the tip.A video was provided.The lens and cartridge preparation were not shown.The lens was advanced slightly outside the eye.Very little ovd was observed in front of the lens as it was advanced.As the cartridge tip was inserted into the incision, pressure was applied which moved the eye up and out of view under the upper eyelid.The lens delivery could not be visualized due to this position.The lens was quickly advanced.The pressure on the eye was release allowing the eye to resume a normal position.As the lens unfolded, a narrow linear material was observed on the left side of the posterior surface originating near the optic/haptic junction.The material was removed with the i/a tip after several attempts/manipulations.The lens remained implanted.The lens appears to be the lens in the provided photo.Product history records were reviewed, and documentation indicated the product met release criteria.A qualified lens model/diopter and handpiece were indicated.A non-qualified viscoelastic was indicated.The root cause for the reported issue could not be determined.Based on the review of the provided video and the returned used company cartridge, the reported foreign material may have been internal coating material from the damaged company cartridge tip.The removed material was not returned for evaluation.A non-qualified viscoelastic was indicated and there did not appear to be adequate viscoelastic in the used cartridge.Per the ifu: the company iol delivery system is for implantation of qualified company foldable iols.No unqualified lenses should be used with the company iol delivery system.The company cartridges are qualified for use with compatible company handpieces for the surgical implantation of company qualified foldable iols.Company foldable iols are qualified for use with an company qualified delivery system (handpiece and cartridge) and ophthalmic viscosurgical device (ovd) combination.The use of an unqualified combination may cause damage to the iol and potential complications during the implantation process.The ifu instructs to completely fill the cartridge with ovd (diagram provided) immediately prior to loading and delivery of the lens.Do not attempt to load the lens without adequate ovd in the device.Not adequately filling the device with viscoelastic will result in inadequate coverage of lens and the lens fold path with ovd, which may result in damage.Company lens ifu note: during lens loading and insertion, do not allow the company toric iol to remain in a folded condition within the selected iol delivery system for more than 3 minutes prior to completing insertion into the capsular bag there are six other complaints reported in the lot.The manufacturer internal reference number is: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MONARCH III IOL DELIVERY SYSTEM, CARTRIDGE D
Type of Device
FOLDERS AND INJECTORS, INTRAOCULAR LENS (IOL)
Manufacturer (Section D)
ALCON RESEARCH, LLC - HUNTINGTON
6065 kyle lane
huntington WV 25702
Manufacturer (Section G)
ALCON RESEARCH, LLC - HUNTINGTON
6065 kyle lane
huntington WV 25702
Manufacturer Contact
jonathan schlech
6201 south freeway
mail stop ab2-6
fort worth, TX 76134
8007579780
MDR Report Key15586842
MDR Text Key301594629
Report Number1119421-2022-02166
Device Sequence Number1
Product Code MSS
UDI-Device Identifier00380659777639
UDI-Public00380659777639
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
K063155
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 10/12/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number8065977763
Device Lot Number15374791
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer09/30/2022
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 09/14/2022
Initial Date FDA Received10/12/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured03/08/2022
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
CLAREON MONARCH IV IOL DELIVERY SYSTEM, INJECTOR; CLAREON TORIC IOL; Z-HYALIN FROM ZEISS
Patient SexFemale
-
-